Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by Smokey1958on Dec 02, 2021 9:38am
208 Views
Post# 34189397

In the News

In the NewsFor anyone still reluctant to admit that AcuVid still has plenty of opportunity around the planet ....the world clearly thinks differently.

The headline for the following article from Australia:

SA's rapid antigen test ban needs a rapid rethink

https://indaily.com.au/opinion/2021/12/02/sas-rapid-antigen-test-ban-needs-a-rapid-rethink/

A school in the US that is going to employ rapid antigen tests to limit the necessity of quarantine.

https://www.ledgertranscript.com/ConVal-Institutes-New-Testing-Protocol-43784691

In Malaysia the government initiates protocols to insure sufficient and ongoing supply of rapid antigen test kits.

Demand in all manner of situations continues to rise. The new variant(s) (yes there will be more if we don't get our world vaccination policies in order) will make testing even more important.

GLTE ....waiting in anticipation of the next NR ...it should be a great one!!!

<< Previous
Bullboard Posts
Next >>